Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds suitable for the treatment of dyslipidemia

Heterocyclic compounds suitable for the treatment of dyslipidemia

US Patent 8822414 · Granted Sep 2, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Saroglitazar for the treatment of hepatocellular carcinoma2025
Treatment for primary biliary cholangitis2024
Substituted oxazolidinones for the treatment of mammalian infections2024
Treatment for primary biliary cholangitis2024
Trial stimulation systems2023
Trial stimulation systems2022
Treatment for primary biliary cholangitis2022
Trial stimulation systems2022
Peptide based PCSK9 vaccine2022
Process for the preparation of quinolone based compounds2021
Smart commissioning for first responders in incident command system2020
Wireless device based auto check-in and information sourcing system for accounta2020